Diuretic therapy in fluid-overloaded and heart failure patients

Rinaldo Bellomo, John R. Prowle, Jorge E. Echeverri

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

10 Citations (Scopus)

Abstract

Diuretics are the most commonly used drugs to treat clinically diagnosed fluid overload in patients with heart failure. There is no conclusive evidence that they alter major outcomes such as survival to hospital discharge or time in hospital compared to other therapies. However, they demonstrably achieve fluid removal in the majority of patients, restore dry body weight, improve the breathlessness of pulmonary edema and are unlikely to be subjected to a large double-blind randomized controlled trial in this setting because of lack of equipoise. The effective and safe use of diuretics requires physiological understanding of the pharmacokinetics and pharmacodynamics of diuretic therapy, an appreciation of the clinical goals of diuretic therapy, the application of physiological targeting of dose, an understanding of the effects of hemodynamic impairment on their ability to achieve fluid removal, an appreciation of the effects of combinations of different diuretics in patients refractory to single agents and an understanding of the most common side effects of such therapy. The use of continuous infusions of loop diuretics, sometimes combined with carbonic anhydrase inhibitors and/or aldosterone antagonists and/or thiazide diuretics can prove particularly effective in patients with advanced heart failure. Such therapy often requires more intensive monitoring than available in medical wards. If diuretic therapy fails to achieve its clinical goals, ultrafiltration by semipermeable membranes is reliably effective in achieving targeted fluid removal. The combination of diuretic therapy and/or ultrafiltration can achieve volume control in essentially all patients with heart failure.

Original languageEnglish
Title of host publicationFluid Overload
Subtitle of host publicationDiagnosis and Management
EditorsClaudio Ronco, Maria Costanzo, Rinaldo Bellomo, Alan Maisel
Pages153-163
Number of pages11
DOIs
Publication statusPublished - 1 Apr 2010

Publication series

NameContributions to Nephrology
Volume164
ISSN (Print)0302-5144

Cite this

Bellomo, R., Prowle, J. R., & Echeverri, J. E. (2010). Diuretic therapy in fluid-overloaded and heart failure patients. In C. Ronco, M. Costanzo, R. Bellomo, & A. Maisel (Eds.), Fluid Overload: Diagnosis and Management (pp. 153-163). (Contributions to Nephrology; Vol. 164). https://doi.org/10.1159/000313728
Bellomo, Rinaldo ; Prowle, John R. ; Echeverri, Jorge E. / Diuretic therapy in fluid-overloaded and heart failure patients. Fluid Overload: Diagnosis and Management. editor / Claudio Ronco ; Maria Costanzo ; Rinaldo Bellomo ; Alan Maisel. 2010. pp. 153-163 (Contributions to Nephrology).
@inbook{4590183130f34a8f824f9257b42ce681,
title = "Diuretic therapy in fluid-overloaded and heart failure patients",
abstract = "Diuretics are the most commonly used drugs to treat clinically diagnosed fluid overload in patients with heart failure. There is no conclusive evidence that they alter major outcomes such as survival to hospital discharge or time in hospital compared to other therapies. However, they demonstrably achieve fluid removal in the majority of patients, restore dry body weight, improve the breathlessness of pulmonary edema and are unlikely to be subjected to a large double-blind randomized controlled trial in this setting because of lack of equipoise. The effective and safe use of diuretics requires physiological understanding of the pharmacokinetics and pharmacodynamics of diuretic therapy, an appreciation of the clinical goals of diuretic therapy, the application of physiological targeting of dose, an understanding of the effects of hemodynamic impairment on their ability to achieve fluid removal, an appreciation of the effects of combinations of different diuretics in patients refractory to single agents and an understanding of the most common side effects of such therapy. The use of continuous infusions of loop diuretics, sometimes combined with carbonic anhydrase inhibitors and/or aldosterone antagonists and/or thiazide diuretics can prove particularly effective in patients with advanced heart failure. Such therapy often requires more intensive monitoring than available in medical wards. If diuretic therapy fails to achieve its clinical goals, ultrafiltration by semipermeable membranes is reliably effective in achieving targeted fluid removal. The combination of diuretic therapy and/or ultrafiltration can achieve volume control in essentially all patients with heart failure.",
author = "Rinaldo Bellomo and Prowle, {John R.} and Echeverri, {Jorge E.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1159/000313728",
language = "English",
isbn = "9783805594165",
series = "Contributions to Nephrology",
pages = "153--163",
editor = "Claudio Ronco and Maria Costanzo and Rinaldo Bellomo and { Maisel}, Alan",
booktitle = "Fluid Overload",

}

Bellomo, R, Prowle, JR & Echeverri, JE 2010, Diuretic therapy in fluid-overloaded and heart failure patients. in C Ronco, M Costanzo, R Bellomo & A Maisel (eds), Fluid Overload: Diagnosis and Management. Contributions to Nephrology, vol. 164, pp. 153-163. https://doi.org/10.1159/000313728

Diuretic therapy in fluid-overloaded and heart failure patients. / Bellomo, Rinaldo; Prowle, John R.; Echeverri, Jorge E.

Fluid Overload: Diagnosis and Management. ed. / Claudio Ronco; Maria Costanzo; Rinaldo Bellomo; Alan Maisel. 2010. p. 153-163 (Contributions to Nephrology; Vol. 164).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Diuretic therapy in fluid-overloaded and heart failure patients

AU - Bellomo, Rinaldo

AU - Prowle, John R.

AU - Echeverri, Jorge E.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Diuretics are the most commonly used drugs to treat clinically diagnosed fluid overload in patients with heart failure. There is no conclusive evidence that they alter major outcomes such as survival to hospital discharge or time in hospital compared to other therapies. However, they demonstrably achieve fluid removal in the majority of patients, restore dry body weight, improve the breathlessness of pulmonary edema and are unlikely to be subjected to a large double-blind randomized controlled trial in this setting because of lack of equipoise. The effective and safe use of diuretics requires physiological understanding of the pharmacokinetics and pharmacodynamics of diuretic therapy, an appreciation of the clinical goals of diuretic therapy, the application of physiological targeting of dose, an understanding of the effects of hemodynamic impairment on their ability to achieve fluid removal, an appreciation of the effects of combinations of different diuretics in patients refractory to single agents and an understanding of the most common side effects of such therapy. The use of continuous infusions of loop diuretics, sometimes combined with carbonic anhydrase inhibitors and/or aldosterone antagonists and/or thiazide diuretics can prove particularly effective in patients with advanced heart failure. Such therapy often requires more intensive monitoring than available in medical wards. If diuretic therapy fails to achieve its clinical goals, ultrafiltration by semipermeable membranes is reliably effective in achieving targeted fluid removal. The combination of diuretic therapy and/or ultrafiltration can achieve volume control in essentially all patients with heart failure.

AB - Diuretics are the most commonly used drugs to treat clinically diagnosed fluid overload in patients with heart failure. There is no conclusive evidence that they alter major outcomes such as survival to hospital discharge or time in hospital compared to other therapies. However, they demonstrably achieve fluid removal in the majority of patients, restore dry body weight, improve the breathlessness of pulmonary edema and are unlikely to be subjected to a large double-blind randomized controlled trial in this setting because of lack of equipoise. The effective and safe use of diuretics requires physiological understanding of the pharmacokinetics and pharmacodynamics of diuretic therapy, an appreciation of the clinical goals of diuretic therapy, the application of physiological targeting of dose, an understanding of the effects of hemodynamic impairment on their ability to achieve fluid removal, an appreciation of the effects of combinations of different diuretics in patients refractory to single agents and an understanding of the most common side effects of such therapy. The use of continuous infusions of loop diuretics, sometimes combined with carbonic anhydrase inhibitors and/or aldosterone antagonists and/or thiazide diuretics can prove particularly effective in patients with advanced heart failure. Such therapy often requires more intensive monitoring than available in medical wards. If diuretic therapy fails to achieve its clinical goals, ultrafiltration by semipermeable membranes is reliably effective in achieving targeted fluid removal. The combination of diuretic therapy and/or ultrafiltration can achieve volume control in essentially all patients with heart failure.

UR - http://www.scopus.com/inward/record.url?scp=77955483307&partnerID=8YFLogxK

U2 - 10.1159/000313728

DO - 10.1159/000313728

M3 - Chapter (Book)

SN - 9783805594165

T3 - Contributions to Nephrology

SP - 153

EP - 163

BT - Fluid Overload

A2 - Ronco, Claudio

A2 - Costanzo, Maria

A2 - Bellomo, Rinaldo

A2 - Maisel, Alan

ER -

Bellomo R, Prowle JR, Echeverri JE. Diuretic therapy in fluid-overloaded and heart failure patients. In Ronco C, Costanzo M, Bellomo R, Maisel A, editors, Fluid Overload: Diagnosis and Management. 2010. p. 153-163. (Contributions to Nephrology). https://doi.org/10.1159/000313728